InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Wednesday, 07/26/2017 2:46:49 AM

Wednesday, July 26, 2017 2:46:49 AM

Post# of 345746
Good Morning!

PEREGRINE PHARMACEUTICALS INC FILES -- 8-K
EDG
25/07/2017 11:00 PM

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20170725:EDG_0001683168-17-001855





Item 8.01 Other Events.


On July 24, 2017, Peregrine Pharmaceuticals, Inc. (the "Company") received a letter from the Nasdaq Office of General Counsel notifying the Company that it has regained compliance with the $1.00 minimum closing bid price requirement set forth in the NASDAQ Listing Rule 5550(a)(2), and is in compliance with other applicable requirements for listing on The Nasdaq Stock Market. Accordingly, the NASDAQ has determined to continue the listing of the Company’s securities on The Nasdaq Stock Market and considers the matter closed.

nEOLbkLVRF

© Thomson Reuters 2017. All rights reserved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News